Background: Matrix-metalloproteinases (MMP) and cancer cell invasion are crucial for solid tumour metastasis. Important signalling events triggered by inflammatory cytokines, such as tumour necrosis factor α (TNFα), include Src-kinase-dependent activation of Akt and focal adhesion kinase (FAK) and phosphorylation of caveolin-1. Based on previous studies where we demonstrated amide-type local anaesthetics block TNFα-induced Src activation in malignant cells, we hypothesized that local anaesthetics might also inhibit the activation and/or phosphorylation of Akt, FAK and caveolin-1, thus attenuating MMP release and invasion of malignant cells. Methods: NCI-H838 lung adenocarcinoma cells were incubated with ropivacaine or lidocaine (1 nM-100 µM) in absence/ presence of TNFα (20 ng ml
these findings provide significant insight into the potential mechanism by which local anaesthetics might diminish metastasis.
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Editor's key points
• Anaesthetic techniques may have an impact on outcome from cancer surgery.
• Local anaesthetics have anti-inflammatory effects which may impact upon cancer cell invasion.
• Lung adenocarcinoma cells were exposed to ropivacaine or lidocaine at clinically relevant concentrations.
• Both local anaesthetics blocked tumour cell invasion and metalloproteinase expression via effects on Src signalling.
• This provides some insight into the mechanisms behind the effects of local anaesthetics on cancer cell invasion.
There is conflicting evidence regarding the effect of anaesthesia technique and patient outcome after cancer surgery. 1 Retrospective analyses indicate the perioperative use of regional anaesthesia using amide-linked local anaesthetics (LAs) may decrease cancer recurrence and metastasis in these patients. [2] [3] [4] Anti-inflammatory effects of LAs in various epithelial and endothelial cell types are well known. 5 6 The fact that LAs have anti-inflammatory properties in malignant cells lead to our recent observations that amide-type LAs inhibit the activation of inflammatory Src tyrosine protein kinase (Src), a critical mediator of endothelial hyperpermeability and also cancer cell extravasation and metastasis. 7 8 Matrix-metalloproteinases (MMPs) are important in the pathogenesis of new metastatic sites from solid tumours as these enzymes degrade the extracellular matrix and basal lamina, thus allowing malignant cells to enter or escape the primary tumour, enter the circulation, and extravasate to form satellite lesions. 9 10 De novo synthesis of MMPs [e.g. due to stimulation with tumour necrosis factor α (TNFα)], largely depends on Src-dependent activation of Akt and focal adhesion kinase (FAK) and phosphorylation of caveolin-1 (Cav-1) by Src, 11 signalling pathways which are also required for cancer cell migration. [12] [13] [14] In the present study, we tested the hypothesis that amidetype local anaesthetics such as lidocaine and ropivacaine inhibit TNFα-induced Akt and FAK activation and Src-dependent Cav-1 phosphorylation, thus attenuating MMP-9 secretion, migration, and invasion of lung adenocarcinoma cells (Fig. 1 ).
Methods

Cell culture
Human NCI-H838 lung adenocarcinoma cells (CRL-5844, ATCC, Rockville, MD) were cultured as previously described. 7 All cells were maintained in 5% CO 2 and 95% room air in a water-jacketed 37°C incubator.
Experimental procedure
NCI-H838 cell monolayers were incubated with TNFα (Gibco Invitrogen, Carlsbad, CA, final concentration 20 ng ml 
Cell harvest and lysis
After indicated incubation times, cells were harvested and lysed as described previously. 15 Total protein concentration was determined using the DC Protein Assay Kit (BioRad, Hercules, CA) in accordance with the manufacturer's instructions. Immunoglobulin G was used for the generation of a standard curve.
Western blot analysis
Whole cell lysates were subjected to Western blot analysis following a published protocol. 16 Antibodies against FAK, phosphorylated at tyrosine 397 (pY397), total FAK, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and total Akt were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), against phospho-tyrosine 14 (pY14) Cav-1, total Cav-1, and β-actin from BD Biosciences (Franklin Lakes, NJ), and for Akt, phosphorylated at threonine 308 (pT308), from Cell Signaling Technology (Danvers, MA). 
Enzyme-linked immunosorbent assay (ELISA)
The concentration of MMP-9 in cell culture supernatant was determined using the human MMP- In vitro invasion assay ). The cell suspension was inoculated in the upper chamber of the Transwell, which was then inserted into a 24-well cell culture plate (TPP Techno Plastic Products, Trasadingen, Switzerland). The bottom chamber of the system was pre-filled with RPMI-1640 medium supplemented with 10% FBS plus TNFα and LA as in each corresponding upper chamber. Cells were allowed to invade into the Matrigel-coated membrane for 6 h. Non-invading cells were removed, invading cells were fixed with 2% paraformaldehyde solution (Kantonsapotheke Zurich, Zurich, Switzerland) and stained with 4′,6-diamidino-2-phenylindole (DAPI, Life Technologies, Zug, Switzerland). Membranes were mounted on glass slides for microscopy and quantitative image analysis. Images were acquired at 20× magnification using a Leica DM6000B microscope equipped with a DFC350FX camera and Leica Application Suite Advanced Fluorescence software, Version 3.x for Windows (all from Leica Microsystems, Heerbrugg, Switzerland). Semi-automated counting of cell nuclei stained with DAPI was carried out using the ImageJ software, Version 1.47v for Mac (http://imagej. nih.gov/ij). Eight fields of view (0.2 mm 2 each) were quantified per slide and averaged for further analysis.
Statistical analysis
Normal distribution was assessed using Shapiro-Wilk testing.
Normally distributed data of transepithelial resistance were analysed by one-way ANOVA. Non-normally distributed data (invasion) were analysed with non-parametric testing (KruskalWallis and subsequent Mann-Whitney U-tests) with post hoc corrections using the Simes-Hochberg method in order to keep the family-wise error rate below 0.05. All other data were evaluated with two-way ANOVA with the local anaesthetic (or other treatments) and the absence or presence of TNFα as factors to be tested, whereas we report the F ratio with the degrees of freedom for each of these factors and for the interaction between them. Bonferroni post hoc testing was conducted to detect differences between groups. The exact number of experiments is indicated in the respective figure legend. All tests were performed two-sided and non-blinded using GraphPad Prism software for Mac, Version 6 (GraphPad Software). A p-value of <0.05 was considered statistically significant. The half-maximal inhibitory concentration (IC 50 ) 18 was assessed for lidocaine and ropivacaine on TNFα-induced MMP-9 secretion by NCI-H838 lung cancer cells by plotting the MMP-9 concentration against the (logarithmic) concentration of the local anaesthetic. Curve fitting (Hill slope fixed at −1.0) was conducted using non-linear regression analysis with the following equation:
Results reported in Table 1 are values with 95% confidence interval (CI, for IC 50 , top, and bottom).
Results
Cytotoxic effects of local anaesthetics at the concentrations used were excluded in a previous study. 7 Representative Western blots of the activated form of Akt, phosphorylated at threonine 308 ( pT308 Akt), total Akt, and GAPDH are shown in Figure 2A The same samples were also evaluated for FAK phosphorylation at tyrosine 397 ( pY397 FAK) as compared to the total We also assessed the effect of lidocaine and ropivacaine on TNFα-induced Cav-1 phosphorylation at tyrosine 14 via Western blot (pY14 Cav-1, Fig 3A and B) . TNFα significantly increased pY14 Cav-1 by 75% [51%], (F(1,60)=4.22, P=0.04, Fig. 3Ci ) and 49% [36%] (F(1,65)=5.42, P=0.02, Fig. 3Cii ), respectively. It also became evident that both LAs completely blocked TNFα-induced Cav-1 phosphorylation at concentrations of 1 µM (P=0.002 for lidocaine, P=0.004 for ropivacaine). Non-linear curve fitting was used to determine IC 50 values of lidocaine and ropivacaine on TNFα-induced MMP-9 secretion as shown in Table 1 : the IC 50 for lidocaine was 3.29 µM (95% CI, 1.36-7.98 µM) with a maximum effect of 62% (95% CI, 51-75%) whereas ropivacaine had a lower IC 50 (152 pM, 95% CI, 42-557 pM) and a lower maximum effect of 30% (95% CI, 17-42%, all Table 1 
Discussion
In this study, we evaluated the effect of lidocaine and ropivacaine on TNFα-induced, Src-dependent inflammatory signalling events in malignant cells, namely activation of Akt and FAK and phosphorylation of Cav-1. As hypothesized, these signalling events were blocked in presence of the amide-linked LAs. We then also linked inhibition of this inflammatory signalling downstream of TNFα and Src to function, assessing the effect of LAs on MMP-9 production, migration, and invasion of H838 cells, further elucidating a potential mechanism by which local anaesthetics might be able to attenuate metastasis of solid epithelial tumours.
Mechanisms similar to inflammatory processes may play an important role in the development, growth, and metastasis of solid tumours. [19] [20] [21] We have previously shown that amidelinked local anaesthetics, such as lidocaine and ropivacaine, inhibit TNFα-induced activation of Src by blocking the early propagation of signalling at the level of TNFα receptor-1 (TNF-R1). 7 8 Activated Src functions to increase vascular permeability, 22 cancer and inflammatory cell adhesion to the endothelium, and cancer cell migration. Additionally, Src is involved in signalling epithelial-to-mesenchymal transformation and extravasation of cancer cells, processes that are necessary for solid tumour metastasis. 19 23 The release of MMPs by neutrophils and malignant cells alike is known to contribute to tumour growth and metastasis by degrading the extracellular matrix and breaking up the basal lamina, thereby enabling cancer cells to enter and then exit the circulation at a remote location. 9 10 TNFα-induced expression of MMPs by malignant cells is Src-dependent and involves the PI3 K/Akt pathway. 11 Activation of Akt by PI3K is Src-dependent and involved in numerous downstream signalling events that contribute to cancer cell growth, proliferation and survival and has therefore become a very interesting protein for targeted therapies. 24 The results of our study clearly show that both lidocaine and ropivacaine significantly inhibit Akt activation in NCI-H838 non-small cell lung cancer (NSCLC) cells, thus attenuating MMP-9 production. Cav-1 is a primary Src substrate 22 and Src-dependent Cav-1 Y14 phosphorylation is important for migration of (malignant) cells via the regulation of focal adhesion dynamics and assembly, 12 14 which also involves the PI3K/Akt pathway. 25 pY14-Cav-1 promotes tumour growth whereas loss of Cav-1 expression in either the tumour microenvironment or cancer cells per se leads to a significant increase in invasiveness and overall worse prognosis. [26] [27] [28] As we have previously shown that tyrosine phosphorylation of Cav-1 promotes its degradation, 16 reduction of pY14 Cav-1 as seen in our study may be a mechanism by which the LAs reduce the metastatic potential of malignant cells. FAK is the most important kinase in focal adhesion signalling and its activation is not only PI3K-and Src-dependent, 29 30 but also crucial for cell orientation, actin cytoskeletal assembly/reorganization, and ultimately cancer cell migration. 12 13 31 The results from our study confirm these previous findings. We showed that enhanced cancer cell migration induced by TNFα was impaired by the PI3K inhibitor wortmannin, the specific FAK inhibitor FI 14, and importantly, lidocaine and ropivacaine had a similar effect. In order to combine findings on the effect of LAs on TNFα-signalling, migration, and MMP secretion, we assessed the impact of lidocaine and ropivacaine on tumour cell invasion into a collagen-rich environment in vitro. We demonstrated that the amide-linked local anaesthetics lidocaine and ropivacaine were able to completely mitigate TNFα-induced enhancement in invasion and showed that inhibition of Akt activation and FAK had the same effect. These findings are in accordance with results from experiments conducted by Baptista and colleagues 32 ,
where ropivacaine was also demonstrated to inhibit invasion of metastatic colon cancer cells (SW620), as a result of an inhibition of the Na v 1.5 subset of voltage-gated sodium channels (VGSC). However, we previously showed that lidocaine and ropivacaine (amide-linked LAs), but not chloroprocaine (ester-type LA), inhibit TNFα-induced Src activation and downstream signalling in NCI-H838 lung cancer cells independently of VGSC blockade, 7 further supporting our hypothesis that LAs exhibit antiinflammatory and anti-metastatic effects, by blocking TNFα signalling at the level of its receptor, TNF-R1. 8 Taken together with results of PI3K inhibitor wortmannin and FAK inhibitor FI 14, the observed attenuation of cancer cell invasion by lidocaine and ropivacaine is likely to be as a result of the blockade of Src-dependent Akt and FAK activation and of Cav-1 phosphorylation.
In summary, cancer dissemination is a multi-step process where many cellular and molecular regulatory mechanisms may be targets for therapeutic interventions. This study clearly demonstrates the importance of the blockade of the Src pathway by clinically relevant concentrations of amide LAs and-most importantly-explores this pathway further downstream, linking the interference with this particular pathway to the invasion of malignant cells.
Although determined entirely in vitro, the current study provides new and significant insight into a potential mechanism by which amide-LAs might attenuate metastasis.
